G

Gritstone bio

202 employees

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Basic info

Industry

biotechnology

Sectors

COVID-19
Biotechnology
Health Care
HIV
cancer vaccines
infectious disease immunotherapies
Therapeutics
immuno-oncology
oncology
precision therapy
personalized medicine

Date founded

2015

Funding rounds raised

Total raised

$125M

from 23 investors over 23 rounds

G

Gritstone bio raised $80M on July 22, 2022

Investors: Hercules Capital, Inc.

G

Gritstone bio raised $55M on September 16, 2021

Investors: Redmile Group, Gilead Sciences and Frazier Healthcare Partners

G

Gritstone bio raised $21M on August 17, 2021

Investors: CEPI (Coalition for Epidemic Preparedness Innovations)

G

Gritstone bio raised $125M on December 28, 2020

Investors: Redmile Group, Avidity Partners and Versant Ventures

G

Gritstone bio raised $21M on June 1, 2018

Investors: Redmile Group

G

Gritstone bio raised undisclosed on October 1, 2017

Investors: Bay City Capital

G

Gritstone bio raised $93M on September 7, 2017

Investors: Lilly Asia Ventures, The Column Group, Redmile Group, GV, Frazier Healthcare Partners, Versant Ventures and Clarus Ventures, LLC

G

Gritstone bio raised $102M on October 20, 2015

Investors: Versant Ventures, Redmile Group, Frazier Healthcare Partners, The Column Group, Clarus Ventures, LLC and Casdin Capital, LLC

FAQ